Semaglutide Cost Explained: List Price, Coverage, and Savings

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Search "semaglutide cost" and you will get a dozen different numbers. That is not an accident. This guide, part of the PlexusDx Education Hub, unpacks why the figure moves around so much and what actually determines the amount you hand over at the pharmacy window. Browse every GLP-1 and peptide guide here.

Why one drug shows up at so many prices

A single molecule can be quoted at wildly different amounts because the price depends on layers most shoppers never see: the plan you carry, the FDA-approved indication written on the prescription, any manufacturer savings program you qualify for, the pharmacy's own contract, and whether a compounded formulation is available through a licensed pathway. Strip those away and you are left with the list price, which is where the confusion starts.

The April 2026 list price

As of April 2026, semaglutide carries a U.S. list price of roughly $968 to $1,029 per month according to Novo Nordisk's published figures. Treat that as a ceiling, not a forecast. List price is the sticker before insurance, rebates, savings cards, and pharmacy negotiation touch it, so very few insured patients ever pay the full amount.

How coverage reshapes the bill

Whether a commercial plan pays anything hinges on the indication on your script and that plan's formulary rules. Type 2 diabetes coverage for GLP-1 receptor agonists is common. Coverage written for chronic weight management is far less predictable, frequently gated behind BMI-based prior authorization, and sometimes excluded outright. Medicare, as of April 2026, does not pay for FDA-approved weight-loss drugs on the basis of weight alone, though certain cardiovascular indications are covered for some products. Confirm the specifics with your own plan.

Savings cards, coupons, and the fine print

Novo Nordisk runs a manufacturer savings card that can meaningfully lower monthly cost for eligible commercially insured patients. Government programs such as Medicare, Medicaid, and TRICARE are generally excluded, and every card carries monthly and annual caps that shift over time, so verify current terms at fill. Separately, discount platforms like GoodRx and SingleCare post cash coupon prices that differ pharmacy to pharmacy.

The compounding chapter, 2024 to 2025

While the FDA listed semaglutide and tirzepatide in shortage, 503A compounding pharmacies were permitted to prepare compounded versions of these molecules. The semaglutide shortage was declared resolved in late 2024 and tirzepatide in early 2025, which tightened that window without shutting down every legitimate compounding pathway. Compounded preparations are not the same as the FDA-approved brand, are not generics, and carry their own separate pricing.

Estimating your own number

Three broad scenarios cover most people. With a plan that covers the indication and an applied savings card, eligible patients may land near $25 per month depending on caps. With commercial insurance that excludes the indication, expect cash-pay closer to list price minus any coupon. Without insurance, cash-pay approaches list; PlexusDx Weight Management Protocols publish separate per-protocol pricing on each product page.

The genetic layer most cost guides skip

PlexusDx offers semaglutide and tirzepatide as Semaglutide Injection, Semaglutide Oral, and their tirzepatide counterparts. What comes first, though, is context. The Precision Peptide Genetic Test reads 14 pathways, 49 peptides, 150+ genetic insights, including FTO, GLP1R, and MC4R variants that shape baseline appetite regulation and energy balance. It never predicts how you will respond to a specific drug; it simply frames the biology you and your provider are working with before dollars enter the conversation.

Frequently Asked Questions

What is the monthly list price of semaglutide right now?

Novo Nordisk's published U.S. list price sits at approximately $968 to $1,029 per month as of April 2026. That figure precedes insurance, rebates, and coupons, so most patients pay less. Always confirm the live price with your dispensing pharmacy before the prescription is filled.

Will my insurance pay for semaglutide?

It depends on your formulary, the FDA indication on the script, and prior authorization rules. Diabetes coverage is fairly routine among commercial plans, while weight-management coverage varies widely. Medicare does not cover weight-loss use on the basis of weight alone as of April 2026.

Do coupons actually lower the price?

They can. The Novo Nordisk savings card helps eligible commercially insured patients, and platforms like GoodRx post cash discounts that vary by location. Patients on government insurance are usually excluded from the manufacturer card, so check current eligibility and caps at the time you fill.

Is a compounded version cheaper than the brand?

Licensed 503A pharmacies prepare compounded semaglutide at separate price points from the FDA-approved brand, but the two are legally and chemically distinct, not interchangeable generics. PlexusDx lists semaglutide and tirzepatide through its Weight Management Protocols with per-protocol pricing shown on each product page.

Ground your decision in biology first. Take the Precision Peptide Genetic Test, then continue exploring the Education Hub.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.